Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CYBERSECURITY Advice is pouring in for the Department of Homeland Security’s as yet unnamed new…
Op-Eds
PETA or Medical Research? by Steven J. Milloy
People for the Ethical Treatment of Animals launched a campaign last week against a drug testing company for alleged violations of animal welfare laws.<?xml:namespace…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TRANSPORTATION Transportation Secretary Norman Mineta warns Amtrak that federal funds may not be available to bail…
Op-Eds
Infant Formula Ambush by Henry I. Miller
Self-styled public-health activists often pursue issues that are surrogates for their real agenda. One example is the continuing attack on infant formula. Activists'…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. SPAM E-MAIL Spam “zombies”—computers that are hijacked to send out a spammer’s unwanted email messages—get…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TECHNOLOGY A small group of U.S. House members is proposing new federal rules for disposal…